Dendrimer-Based Nanoparticle Therapies: Can Uniform Multifunctional Therapeutics Be Made with Current Chemical Approaches?
D. G. Mullen, D. Q. McNerny, M. M. Banaszak Holl, J. R. Baker
2012
Design, Synthesis, and Biological Functionality of a Dendrimer-based Modular Drug Delivery Platform
. D. Mullen, D. McNerny, A. Desai, X.-M. Chen, S. DiMaggio, A. Kotlyar, Y. Zhong, S. Qin, C. V. Kelly, T. Thomas, I. Majoros, B. G. Orr, J. R. Baker, M. M. Banaszak Holl
Bioconjugate Chemistry
2011
22,
679-689
Effect of Mass Transport in the Synthesis of Partially Acetylated Dendrimer: Implications for Functional Ligand-Nanoparticle Interactions
D. G Mullen, E. L. Borgmeier, M. Fang, D. Q. McNerny, A. Desai, J. R. Baker, B. G. Orr, M. M. Banaszak Holl
Macromolecules
2010,
43,
6577-6587.
RGD Dendron Bodies: Synthetic Avidity Agents with Defined and Potentially Interchangeable Effector Sites That Can Substitute for Antibodies
D. Q. McNerny, J. F. Kukowska-Latallo, D. G. Mullen, J. M. Wallace, A. M.Desai, R. Shukla, B. Huang, M. M. Banaszak Holl, J. R. Baker
Bioconjugate Chemistry
2009,
20,
1853-1859.
The Implications of Stochastic Synthesis for the Conjugation of Functional Groups to Nanoparticles
D. G. Mullen, A. M. Desai, J. N. Waddell, X.-M. Chen, C. V. Kelly, D. Q. McNerny, I. J. Majoros, J. R. Baker, L. M. Sander, B. G. Orr, and M. M. Banaszak Holl
Bioconjugate Chemistry
2008,
19,
1748-1752.
Wide Varieties of Cationic Nanoparticles Induce Defects in Supported Lipid Bilayers
P. R. Leroueil, S. A. Berry, K. Duthie, G. Han, V. M. Rotello, D. Q. McNerny, J. R. Baker, Jr.; B. G. Orr, M. M. Banaszak Holl
Nanoletters
2008
8
420-424
